Discover Insights on Our Deep Tech Commercialisation Blog

For many deep-tech and biotech startups, intellectual property is not just part of the business. It is the business. Unlike traditional companies, early-stage deep-tech ventures often have limited physical assets or revenue. Their real value lies in: patents, proprietary processes, platform technologies, specialised know-how, scientific data, and technical expertise. Yet many founders do not fully understand the commercial value of their intellectual property. This creates ri

Many deep-tech and biotech founders believe that strong science will naturally attract funding and commercial success. Unfortunately, this is rarely the case. In reality, investors are not only evaluating the quality of the technology. They are assessing whether the innovation can become a scalable, sustainable business. A scientifically impressive product may still struggle commercially because of: high manufacturing costs, regulatory complexity, unclear market demand, limit